Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome

Intensive Care Medicine

Volumn 37, Issue 3, 2011, Pages 525-532

  Hall, Mark W ^a,b   Knatz, Nina L ^b   Vetterly, Carol ^c   Tomarello, Steven ^c   Wewers, Mark D ^a   Volk, Hans Dieter ^d   Carcillo, Joseph A ^c,e  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

GM CSF; IL 6; Immune suppression withdrawal; Immunoparalysis; TNF

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE RESPONSE; HOSPITAL INFECTION; HUMAN; IMMUNOPARALYSIS; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PARALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONFIDENCE INTERVALS; CROSS INFECTION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNITY, INNATE; IMMUNOCOMPROMISED HOST; INFANT; INTERLEUKIN-6; MULTIPLE ORGAN FAILURE; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES;

EID: 79953819133     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-010-2088-x     Document Type: Article

References (35)

1. Leclerc F, Leteurtre S, Duhamel A, Grandbastien B, Proulx F, Martinot A, Gauvin F, Hubert P, Lacroix J (2005) Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children. Am J Resp Crit Care Med 171:348-353 (Pubitemid 40223402)
2. Pizzo PA, Rubin M, Freifeld A, Walsh TJ (1991) The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies. J Pediatr 119:679-694
3. Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA (2005) Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 174:3765-3772 (Pubitemid 40354089)
4. Hoffman JA, Weinberg KI, Azen CG, Horn MV, Dukes L, Starnes VA, Woo MS (2004) Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients. Transpl Infect Dis 6:147-155 (Pubitemid 40516682)
5. Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, Muller JM, Docke WD, Kox WJ (1996) Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med 22(Suppl 4):S474-S481 (Pubitemid 26370899)
6. Monneret G, Finck ME, Venet F, Debard AL, Bohe J, Bienvenu J, Lepape A (2004) The anti-inflammatory response dominates after septic shock: Association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 95:193-198 (Pubitemid 39237665)
7. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr (1990) Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 77:204-207 (Pubitemid 20055846)
8. Reinke P, Volk HD (1992) Diagnostic and predictive value of an immune monitoring program for complications after kidney transplantation. Urol Int 49:69-75
9. Ho YP, Sheen IS, Chiu CT, Wu CS, Lin CY (2006) A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol 101:1117-1124
10. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W (1997) Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment. Nat Med 3:678-681 (Pubitemid 27264980)
11. Ploder M, Pelinka L, Schmuckenschlager C, Wessner B, Ankersmit HJ, Fuerst W, Redl H, Roth E, Spittler A (2006) Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock 25:129-134
12. Allen ML, Hoschtitzky JA, Peters MJ, Elliott M, Goldman A, James I, Klein NJ (2006) Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit Care Med 34:2658-2665 (Pubitemid 44413068)
13. Woiciechowsky C, Asadullah K, Nestler D, Schoning B, Glockner F, Docke WD, Volk HD (1998) Diminished monocytic HLA-DR expression and ex vivo cytokine secretion capacity in patients with glioblastoma: Effect of tumor extirpation. J Neuroimmunol 84:164-171 (Pubitemid 28248402)
14. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk HD (2009) GM-CSF to reverse sepsis-associated immunosuppression: A double-blind randomized placebo-controlled multicenter trial. Am J Respir Crit Care Med 180:640-648
15. Kox WJ, Bone RC, Krausch D, Docke WD, Kox SN, Wauer H, Egerer K, Querner S, Asadullah K, von Baehr R, Volk HD (1997) Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: Proof of principle. Arch Intern Med 157(4):389-393 (Pubitemid 27089964)
16. Nakos G, Malamou-Mitsi VD, Lachana A, Karassavoglou A, Kitsiouli E, Agnandi N, Lekka ME (2002) Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med 30:1488-1494 (Pubitemid 34756229)
17. Nierhaus A, Montag B, Timmler N, Frings DP, Gutensohn K, Jung R, Schneider CG, Pothmann W, Brassel AK, Schulte Am Esch J (2003) Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med 29:646-651 (Pubitemid 36523683)
18. Rosenbloom AJ, Linden PK, Dorrance A, Penkosky N, Cohen-Melamed MH, Pinsky MR (2005) Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients. Chest 127:2139-2150
19. Doughty LA, Kaplan SS, Carcillo JA (1996) Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med 24:1137-1143 (Pubitemid 26249363)
20. Pollack MM, Patel KM, Ruttimann UE (1996) Prism iii: An updated pediatric risk of mortality score. Crit Care Med 24:743-752 (Pubitemid 26155716)
21. Bone RC (1996) Sir Isaac Newton, sepsis, sirs, and cars. Crit Care Med 24:1125-1128
22. Volk HD, Reinke P, Docke WD (2000) Clinical aspects: From systemic inflammation to 'immunoparalysis'. Chem Immunol 74:162-177
23. Monneret G, Lepape A, Voirin N, Bohe J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P (2006) Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32:1175-1183 (Pubitemid 44232412)
24. Volk HD, Reinke P, Docke WD (1999) Immunological monitoring of the inflammatory process: Which variables? When to assess? Eur J Surg Suppl 584:70-72
25. Flach R, Majetschak M, Heukamp T, Jennissen V, Flohe S, Borgermann J, Obertacke U, Schade FU (1999) Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis. Cytokine 11:173-178 (Pubitemid 29116558)
26. Spagnoli GC, Juretic A, Rosso R, Van Bree J, Harder F, Heberer M (1995) Expression of HLA-DR in granulocytes of polytraumatized patients treated with recombinant human granulocyte macrophage-colony-stimulating factor. Hum Immunol 43:45-50
27. Lendemans S, Kreuzfelder E, Waydhas C, Schade FU, Flohe S (2007) Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFN gamma) after severe trauma. Inflamm Res 56:38-44 (Pubitemid 46356226)
28. Bundschuh DS, Barsig J, Hartung T, Randow F, Docke WD, Volk HD, Wendel A (1997) Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. J Immunol 158:2862-2871 (Pubitemid 127470547)
29. Flohe S, Lendemans S, Selbach C, Waydhas C, Ackermann M, Schade FU, Kreuzfelder E (2003) Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma. Crit Care Med 31:2462-2469 (Pubitemid 37281730)
30. Fumeaux T, Pugin J (2002) Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Resp Crit Care Med 166:1475-1482 (Pubitemid 35387298)
31. Presneill JJ, Harris T, Stewart AG, Cade JF, Wilson JW (2002) A randomized phase ii trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am J Resp Crit Care Med 166:138-143 (Pubitemid 34765447)
32. Herrmann F, Schulz G, Lindemann A, Meyenburg W, Oster W, Krumwieh D, Mertelsmann R (1988) Yeast-expressed granulocyte-macrophage colony-stimulating factor in cancer patients: A phase 1b clinical study. Behring Inst Mitt 83:107-118 (Pubitemid 19239248)
33. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC (2007) Understanding the inflammatory cytokine response in pneumonia and sepsis: Results of the genetic and inflammatory markers of sepsis (genims) study. Arch Intern Med 167:1655-1663 (Pubitemid 47280347)
34. Bultinck J, Brouckaert P, Cauwels A (2006) The in vivo contribution of hematopoietic cells to systemic TNF and IL-6 production during endotoxemia. Cytokine 36:160-166 (Pubitemid 46275465)
35. Yan SF, Tritto I, Pinsky D, Liao H, Huang J, Fuller G, Brett J, May L, Stern D (1995) Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem 270:11463-11471